Literature DB >> 8326751

Assessment of medical technology: the role of engineers.

J Hutton1.   

Abstract

Assessment of medical technologies is a multidisciplinary activity requiring the participation of engineers, clinicians and social scientists. The contribution of engineers has often been confined to the early stages of technical assessment. However, engineers have important inputs to make throughout the assessment process in their roles of developers, users and managers of technology. Engineers have found collaboration with clinical researchers possible through hospital-based work, but must also develop links with economists and other social scientists if they are to make a full contribution to comprehensive technology assessment.

Mesh:

Year:  1993        PMID: 8326751     DOI: 10.1007/bf02446886

Source DB:  PubMed          Journal:  Med Biol Eng Comput        ISSN: 0140-0118            Impact factor:   2.602


  6 in total

1.  Australian guidelines for cost-effectiveness studies of pharmaceuticals: the thin end of the boomerang?

Authors:  M Drummond
Journal:  Pharmacoeconomics       Date:  1992       Impact factor: 4.981

2.  Avoiding bias in the conduct and reporting of cost-effectiveness research sponsored by pharmaceutical companies.

Authors:  A L Hillman; J M Eisenberg; M V Pauly; B S Bloom; H Glick; B Kinosian; J S Schwartz
Journal:  N Engl J Med       Date:  1991-05-09       Impact factor: 91.245

3.  The poor quality of early evaluations of magnetic resonance imaging.

Authors:  L S Cooper; T C Chalmers; M McCally; J Berrier; H S Sacks
Journal:  JAMA       Date:  1988-06-10       Impact factor: 56.272

4.  Technology assessment and biomedical engineering education.

Authors:  D Menon
Journal:  Med Biol Eng Comput       Date:  1993-01       Impact factor: 2.602

5.  Computerized cranial tomography. Effect on diagnostic and therapeutic plans.

Authors:  H V Fineberg; R Bauman; M Sosman
Journal:  JAMA       Date:  1977-07-18       Impact factor: 56.272

6.  Underreporting research is scientific misconduct.

Authors:  I Chalmers
Journal:  JAMA       Date:  1990-03-09       Impact factor: 56.272

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.